In HCC, Wu et al. investigated the relationship between Kla-specific genes and cancer prognosis, identifying core genes NR6A1, OSBP2, and UNC119B as potential new therapeutic targets for HCC [182]. The gene discussed is KL; the disease is hepatocellular carcinoma.